HK19095A - Pharmaceutical compositions containing ranitidine - Google Patents

Pharmaceutical compositions containing ranitidine Download PDF

Info

Publication number
HK19095A
HK19095A HK19095A HK19095A HK19095A HK 19095 A HK19095 A HK 19095A HK 19095 A HK19095 A HK 19095A HK 19095 A HK19095 A HK 19095A HK 19095 A HK19095 A HK 19095A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
compositions containing
containing ranitidine
ranitidine
ethanol
Prior art date
Application number
HK19095A
Other languages
English (en)
Inventor
Richard Long David
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10608930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK19095(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HK19095A publication Critical patent/HK19095A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
HK19095A 1986-12-12 1995-02-09 Pharmaceutical compositions containing ranitidine HK19095A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868629781A GB8629781D0 (en) 1986-12-12 1986-12-12 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK19095A true HK19095A (en) 1995-02-17

Family

ID=10608930

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19095A HK19095A (en) 1986-12-12 1995-02-09 Pharmaceutical compositions containing ranitidine

Country Status (23)

Country Link
US (1) US5068249A (cs)
JP (1) JP2590156B2 (cs)
KR (1) KR960008228B1 (cs)
AT (1) AT395373B (cs)
AU (1) AU607451B2 (cs)
BE (1) BE1000624A5 (cs)
CA (1) CA1303993C (cs)
CH (1) CH675207A5 (cs)
CZ (1) CZ281599B6 (cs)
DE (1) DE3742127C2 (cs)
DK (1) DK167842B1 (cs)
FR (1) FR2608921B1 (cs)
GB (2) GB8629781D0 (cs)
HK (1) HK19095A (cs)
IE (1) IE60618B1 (cs)
IL (1) IL84795A0 (cs)
IT (1) IT1211967B (cs)
NL (1) NL194431C (cs)
NZ (1) NZ222879A (cs)
PH (1) PH25390A (cs)
SE (1) SE504333C2 (cs)
YU (1) YU46561B (cs)
ZA (1) ZA879338B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
EP0768897A1 (en) * 1994-07-06 1997-04-23 Farmarc Nederland B.V. Inclusion complexes of ranitidine
HU213598B (en) * 1994-10-18 1997-08-28 Ge Lighting Tungsram Rt One-side socketed discharge lamp
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
GB9715423D0 (en) 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
BRPI0714882A2 (pt) * 2006-07-21 2013-05-21 Lyne Lab composiÇço lÍquida de acetato de cÁlcio e uso de uma soluÇço aquosa que compreende entre cerca de 7% (p/v) e cerca de 21% (p/v) de acetato de cÁlcio
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735587A1 (de) * 1977-08-06 1979-02-15 Sandoz Ag Stabile loesungen und verfahren zu deren herstellung
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3108753A1 (de) * 1981-03-07 1982-09-16 Degussa Ag, 6000 Frankfurt Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest
SE8302689L (sv) * 1982-05-14 1983-11-15 Richter Gedeon Vegyeszet Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar
JPS59101478A (ja) * 1982-11-29 1984-06-12 Sunstar Inc リグスチライドを安定に配合した水系組成物
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer

Also Published As

Publication number Publication date
CS403791A3 (en) 1992-08-12
GB8629781D0 (en) 1987-01-21
YU46561B (sh) 1993-11-16
IT1211967B (it) 1989-11-08
CZ281599B6 (cs) 1996-11-13
ATA327387A (de) 1992-05-15
KR960008228B1 (ko) 1996-06-21
DK167842B1 (da) 1993-12-27
NL194431C (nl) 2002-04-04
US5068249A (en) 1991-11-26
AU607451B2 (en) 1991-03-07
KR880007060A (ko) 1988-08-26
SE8704952D0 (sv) 1987-12-11
SE8704952L (sv) 1988-06-13
JP2590156B2 (ja) 1997-03-12
JPS63215622A (ja) 1988-09-08
YU224587A (en) 1990-10-31
CA1303993C (en) 1992-06-23
DE3742127C2 (de) 1997-08-28
IL84795A0 (en) 1988-05-31
BE1000624A5 (fr) 1989-02-21
IE60618B1 (en) 1994-07-27
AU8244487A (en) 1988-06-16
SE504333C2 (sv) 1997-01-13
IT8748698A0 (it) 1987-12-11
FR2608921B1 (fr) 1991-04-12
GB2198352B (en) 1990-11-28
IE873367L (en) 1988-06-12
NZ222879A (en) 1990-08-28
DK652787D0 (da) 1987-12-11
NL8703000A (nl) 1988-07-01
DE3742127A1 (de) 1988-10-06
ZA879338B (en) 1989-02-22
AT395373B (de) 1992-12-10
DK652787A (da) 1988-06-13
NL194431B (nl) 2001-12-03
PH25390A (en) 1991-06-03
CH675207A5 (cs) 1990-09-14
GB2198352A (en) 1988-06-15
GB8728957D0 (en) 1988-01-27
FR2608921A1 (fr) 1988-07-01

Similar Documents

Publication Publication Date Title
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
HK19095A (en) Pharmaceutical compositions containing ranitidine
IE860685L (en) Ô-cyclodextrin derivatives
IE873125L (en) Benzimidazole derivatives
EP0356399A3 (en) Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
DK503687A (da) Farmaceutisk praeparat af ibuprofen
MY100998A (en) Pharmaceutical formulations
IL90551A0 (en) Stable,injectable,aqueous pharmaceutical compositions for the treatment of cardiac conditions
AU590375B2 (en) Aqueous formulation of 1,2-benzisothiazolin-3-one
CS209991A3 (en) Aqueous hydrophilic preparation in the form of a nitroglycerin-containing spray
IE781032L (en) Pharmaceutical compositions
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
HK60894A (en) Pharmaceutical compositions containing furan derivatives
ATE65395T1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
IL57298A0 (en) Pharmaceutical compositions containing prostaglandin derivatives and their preparation
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
IE44339L (en) Piperazine derivatives.
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
HK47592A (en) Piperazine derivatives
EP0279121A3 (en) Pharmaceutical compositions comprising an aqueous solution of a pyranoquinoline derivative
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20071210